Detalles de la búsqueda
1.
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide.
Am J Hematol
; 99(3): 350-359, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38165016
2.
Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamide.
Acta Oncol
; 60(4): 466-474, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33112687
3.
Absence of influence of peripheral blood CD34+ and CD3+ graft cell counts on outcomes after reduced-intensity conditioning transplantation using post-transplant cyclophosphamide.
Ann Hematol
; 99(6): 1341-1350, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32342134
4.
Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life.
Ann Hematol
; 99(7): 1595-1604, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32417940
5.
Influence of Donor Type (Sibling versus Matched Unrelated Donor versus Haploidentical Donor) on Outcomes after Clofarabine-Based Reduced-Intensity Conditioning Allograft for Myeloid Malignancies.
Biol Blood Marrow Transplant
; 25(7): 1465-1471, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30928627
6.
Deauville Scores 4 or 5 Assessed by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Early Post-Allotransplant Is Highly Predictive of Relapse in Lymphoma Patients.
Biol Blood Marrow Transplant
; 25(5): 906-911, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30481598
7.
FLT3 ligand plasma levels have no impact on outcomes after allotransplant in acute leukemia.
Cytokine
; 120: 85-87, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31035172
8.
The MYRACLE protocol study: a multicentric observational prospective cohort study of patients with multiple myeloma.
BMC Cancer
; 19(1): 855, 2019 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31464608
9.
Pomalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients in a real-life setting: a single-center retrospective study.
Ann Hematol
; 98(6): 1441-1447, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30874851
10.
Single-agent daratumumab in very advanced relapsed and refractory multiple myeloma patients: a real-life single-center retrospective study.
Ann Hematol
; 98(6): 1435-1440, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30874850
11.
Interest of a third dose of BNT162b2 anti-SARS-CoV-2 messenger RNA vaccine after allotransplant.
Br J Haematol
; 196(5): e38-e40, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34671982
12.
Safety and antibody response after one and/or two doses of BNT162b2 Anti-SARS-CoV-2 mRNA vaccine in patients treated by CAR T cells therapy.
Br J Haematol
; 196(2): 360-362, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34476803
13.
FLT3 ligand plasma levels in acute myeloid leukemia.
Haematologica
; 104(6): e240-e243, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30630980
14.
B Cell Aplasia Is the Most Powerful Predictive Marker for Poor Humoral Response after BNT162b2 mRNA SARS-CoV-2 Vaccination in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.
Transplant Cell Ther
; 28(5): 279.e1-279.e4, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35218998
15.
Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.
EJHaem
; 2(3): 520-524, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34226903
16.
A new cytokine-based dynamic stratification during induction is highly predictive of survivals in acute myeloid leukemia.
Cancer Med
; 10(2): 642-648, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33369136
17.
Autologous stem-cell collection following VTD or VRD induction therapy in multiple myeloma: a single-center experience.
Bone Marrow Transplant
; 56(2): 395-399, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32796951
18.
Subcutaneous bortezomib incorporated into the bortezomib-thalidomide-dexamethasone regimen as part of front-line therapy in the context of autologous stem cell transplantation for multiple myeloma.
Haematologica
; 99(3): e33-4, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24532044
19.
Clofarabine-based reduced intensity conditioning regimen with peripheral blood stem cell graft and post-transplant cyclophosphamide in adults with myeloid malignancies.
Oncotarget
; 9(71): 33528-33535, 2018 Sep 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30323896
20.
p53 regulates CD46 expression and measles virus infection in myeloma cells.
Blood Adv
; 2(23): 3492-3505, 2018 12 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30530776